Medical errors occur in nearly 50% of surgeries: 4 key notes
A new study indicates medical errors are a much larger problem than previous studies implied, with nearly 50 percent of surgeries encountering a medical error or unintended drug side effect, according to Albany Daily Star.
Boston-based Massachusetts General Hospital researchers examined 277 procedures at the hospital where they observed a high prevalence of medical errors. The figure is higher than previous studies because those studies relied of self-reported medical errors.
Here are four key notes:
1. The most commonly observed mistakes entailed providers administering incorrect dosages.
2. Of the adverse drug events researchers noted that might have led to patient harm, 30 percent were deemed significant and 69 percent were considered serious.
3. Less than 2 percent of adverse drug events were deemed life-threatening.
4. Researchers noted procedures surpassing six hours had a greater chance of subsequent issues.
"We definitely have room for improvement in preventing perioperative medication errors, and now that we understand the types of errors that are being made and their frequencies, we can begin to develop targeted strategies to prevent them," the researchers concluded.
More articles on quality & infection control:
Global surgical instrument tracking systems market to reach $204.8M by 2021: 4 takeaways
3 challenges ASC face in multidisciplinary antibiotic stewardship program implementation
Inpatients vs. outpatient ACL reconstruction: Is there a significant difference in postoperative discomfort?
© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
- Participants race to increase colon cancer awareness during 2017 Greater Chattanooga Rump Run 5K and Fun Walk: 4 takeaways
- US woman dies from superbug resistant to 26 antibiotics — 8 things to know
- Healthcare nanotechnology market to grow at a CAGR above 12% till 2024
- American Anesthesiology to exhibit at ASA's Practice Management 2017: 3 things to know
- Gastroenteropancreatic neuroendocrine tumor patients utilize combination therapy: 5 study insights